MASS Stock Forecast 2025-2026
Distance to MASS Price Targets
MASS Price Momentum
10 Quality Stocks Worth Considering Now
Researching 908 Devices (MASS) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MASS and similar high-potential opportunities.
Latest MASS Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, MASS has a bullish consensus with a median price target of $5.50 (ranging from $5.00 to $6.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $4.76, the median forecast implies a 15.7% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Jacob Johnson at Stephens & Co., projecting a 26.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MASS Analyst Ratings
MASS Price Target Range
Latest MASS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MASS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 15, 2025 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $6.00 |
| Nov 13, 2024 | Leerink Partners | Puneet Souda | Market Perform | Downgrade | $4.00 |
| Nov 13, 2024 | Stifel | Daniel Arias | Buy | Maintains | $6.00 |
| Oct 17, 2024 | Leerink Partners | Outperform | Maintains | $12.00 | |
| May 13, 2024 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $14.00 |
| Sep 25, 2023 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $14.00 |
| Feb 7, 2023 | Stephens & Co. | Jacob Johnson | Overweight | Initiates | $14.00 |
| Jan 6, 2023 | SVB Leerink | Puneet Souda | Outperform | Maintains | $20.00 |
| Nov 15, 2022 | SVB Leerink | Puneet Souda | Outperform | Maintains | $25.00 |
| Mar 8, 2022 | SVB Leerink | Puneet Souda | Outperform | Maintains | $30.00 |
| May 14, 2021 | SVB Leerink | Puneet Souda | Outperform | Maintains | $65.00 |
| Jan 12, 2021 | Stifel | Buy | Initiates | $0.00 | |
| Jan 12, 2021 | Cowen & Co. | Outperform | Initiates | $0.00 | |
| Jan 12, 2021 | SVB Leerink | Outperform | Initiates | $0.00 |
908 Devices Inc. (MASS) Competitors
The following stocks are similar to 908 Devices based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
908 Devices Inc. (MASS) Financial Data
908 Devices Inc. has a market capitalization of $167.99M with a P/E ratio of 0.0x. The company generates $59.63M in trailing twelve-month revenue with a -121.1% profit margin.
Revenue growth is +31.1% quarter-over-quarter, while maintaining an operating margin of -55.7% and return on equity of -51.6%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
908 Devices Inc. (MASS) Business Model
About 908 Devices Inc.
Innovative biotechnology firm developing chemical analysis devices.
908 Devices Inc. designs and manufactures portable analytical tools that cater to various industries, including life sciences and pharmaceuticals. The company generates revenue through the sale of its handheld and desktop devices, which enhance the efficiency and precision of chemical and biochemical analyses.
Focused on real-time analytics, 908 Devices Inc. supports applications in drug development, environmental monitoring, and forensic investigation. Its commitment to miniaturization and engineering excellence allows it to provide sophisticated analytical solutions that facilitate decision-making processes in diverse sectors.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
246
CEO
Dr. Kevin J. Knopp Ph.D.
Country
United States
IPO Year
2020
Website
908devices.com908 Devices Inc. (MASS) Latest News & Analysis
The Nasdaq has entered bear market territory, declining over 20% from its December peak as of Friday.
The Nasdaq's entry into bear market territory signals declining investor confidence in tech stocks, potentially leading to further sell-offs and volatility in the broader market.
New Strong Buy Stocks for April 1st
18 days agoAFRM, TKOMY, FOLD, MASS, and VFC were added to the Zacks Rank #1 (Strong Buy) List on April 1, 2025.
Zacks Rank #1 indicates strong buy potential, suggesting these stocks may outperform the market, attracting investor interest and possibly driving price increases.
Best Momentum Stocks to Buy for March 13th
1 month agoOn March 13, 2025, BK, TKOMY, and MASS were listed as Zacks Rank #1 (Strong Buy) momentum stocks, indicating strong investment potential.
BK, TKOMY, and MASS being ranked as Strong Buy indicates strong investor confidence, potential for price appreciation, and favorable market conditions, attracting interest from growth-focused investors.
908 Devices Receives $1.7M Order from the Ministry of Health of Ukraine for its Handheld Mass Spec Device
1 month ago908 Devices Inc. (Nasdaq: MASS) received a $1.7 million order from Ukraine's Ministry of Health for its MX908 mass spectrometry devices, set for priority shipment in Q1 2025 for environmental testing.
The $1.7 million order from Ukraine signals demand for 908 Devices' technology, potentially boosting revenue and market position in environmental and safety applications.
908 Devices' stock rose after a $70M desktop portfolio sale, doubling cash reserves. The company aims for 11-15% revenue growth in 2025, with reduced losses and positive cash flow expected next year.
908 Devices' stock rise reflects enhanced financial stability from the $70M sale, positioning for growth in handheld devices and potential profitability, which may attract more investors.
908 Devices to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
1 month ago908 Devices Inc. (Nasdaq: MASS) will report Q4 and full-year 2024 financial results on March 4, 2025, before market open, followed by a conference call at 8:30 a.m. ET.
The announcement of 908 Devices' financial results and conference call date signals upcoming insights into the company's performance and future outlook, impacting investor sentiment and stock valuation.
Frequently Asked Questions About MASS Stock
What is 908 Devices Inc.'s (MASS) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, 908 Devices Inc. (MASS) has a median price target of $5.50. The highest price target is $6.00 and the lowest is $5.00.
Is MASS stock a good investment in 2025?
According to current analyst ratings, MASS has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.76. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MASS stock?
Wall Street analysts predict MASS stock could reach $5.50 in the next 12 months. This represents a 15.7% increase from the current price of $4.76. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is 908 Devices Inc.'s business model?
908 Devices Inc. designs and manufactures portable analytical tools that cater to various industries, including life sciences and pharmaceuticals. The company generates revenue through the sale of its handheld and desktop devices, which enhance the efficiency and precision of chemical and biochemical analyses.
What is the highest forecasted price for MASS 908 Devices Inc.?
The highest price target for MASS is $6.00 from Jacob Johnson at Stephens & Co., which represents a 26.2% increase from the current price of $4.76.
What is the lowest forecasted price for MASS 908 Devices Inc.?
The lowest price target for MASS is $5.00 from at , which represents a 5.2% increase from the current price of $4.76.
What is the overall MASS consensus from analysts for 908 Devices Inc.?
The overall analyst consensus for MASS is bullish. Out of 4 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $5.50.
How accurate are MASS stock price projections?
Stock price projections, including those for 908 Devices Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.